Access Bio, Top Search Ranking... Stock Price -2.83%
As of 12:30 PM on the 28th, Access Bio is trading at 27,450 KRW, down 2.83% from the previous day. This represents a 44.82% decline compared to August 19. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.
Over the past five days, individual investors have net purchased 821,778 shares, while foreign investors and institutions have net sold 74,883 shares and 628,188 shares, respectively.
On August 24, Access Bio became a market issue with the headline "Two consecutive trading days of sharp decline... from the 60,000 KRW range down to the 20,000 KRW range."
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
※Source: AI Investment Assistant AI Rasero
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
